Canada Spends Logo

Explore our Budget 2026 analysis

Grant: CIHR Fellowship

Direct Payment

$87,500.00

Genetic dissection of the dopaminergic neuron subtype vulnerable in Parkinson's Disease

FY 2013-14

Summary
The loss of neurons synthesizing dopamine as neurotransmitter, and located in the substantia nigra, underlies motor symptoms of Parkinson's disease. Not all neurons are equally vulnerable to this disease since the nearby dopamine neurons located in the ventral tegmental area are largely spared. Why some neurons are specifically loss in Parkinson's disease is currently unknown. In this proposal, we aim at providing a molecular, anatomical, and functional characterization of dopamine neurons specifically vulnerable in Parkinson disease using novel transgenic tools that allow a genetic access to this neuronal population. This studies will allow to understand the molecular substrates underpinning the selective vulnerability of dopamine neurons, as well as generate novel therapeutic targets.
Program
CIHR Fellowship
Location
Illinois, United States of America
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
300883
Name
Poulin Jean-Francois
Region
Illinois
Country
United States of America
Orgtype
Research Institution
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Biomedical
Prcname2
Fellowships - Post-PhD
Projecttitle
Genetic dissection of the dopaminergic neuron subtype vulnerable in Parkinson's Disease
Programtype2
Fellowship Programs
Orgnameinp2
Direct Payment
Cihramount2
$87,500
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Behavior; Connectomic; Dopamine; Parkinson'S Disease; Transcriptomic; Transgenesis
Abstract
The loss of neurons synthesizing dopamine as neurotransmitter, and located in the substantia nigra, underlies motor symptoms of Parkinson's disease. Not all neurons are equally vulnerable to this disease since the nearby dopamine neurons located in the ventral tegmental area are largely spared. Why some neurons are specifically loss in Parkinson's disease is currently unknown. In this proposal, we aim at providing a molecular, anatomical, and functional characterization of dopamine neurons specifically vulnerable in Parkinson disease using novel transgenic tools that allow a genetic access to this neuronal population. This studies will allow to understand the molecular substrates underpinning the selective vulnerability of dopamine neurons, as well as generate novel therapeutic targets.
Competitiondate
201311
Approvedterm2
1 yr 9 mths
Pinamesdelim
Poulin, Jean-Francois
Approvedterm
1 an 9 mois
Cihrcontribution2
~ $87,500~ $0~
Direct Payment - $87,500 Grant (2013-14) | Canada Spends